In last night’s announcement, Affymax said it was taking these steps “to focus the company’s resources on the ongoing investigation of reported hypersensitivity reactions” to its leading drug. The company was forced to recall its anemia drug, Omontys, in February after 50 patients developed severe allergic reactions to the injectable drug and five people died. Affymax really has no other drug pipeline available to take up the slack from the recall, which may turn out to be permanent. Japan’s Takeda Pharmaceutical Co. is a partner with Affymax in making and distributing Omontys.
Among the strategic alternatives the company is considering are further restructuring, a “wind-down of operations, or even bankruptcy proceedings.”
Shares of Affymax are down more than 56% in premarket trading this morning, at $1.27, well below the 52-week range of $2.26 to $27.74.
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.